Elion Therapeutics
PrivateLast Round
Series B
Jun 17, 2024
Est. Valuation
$163M
Total Funding Raised
$81M
Company Overview
Elion Therapeutics is a biotechnology company that develops next-generation polyene antifungal therapies to treat life-threatening invasive fungal infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elion Therapeutics Comparables
Compare Elion Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| F2G | 83% | |
| Matinas BioPharma Holdings, Inc. | 81% | |
| Appili Therapeutics Inc. | 79% | |
Elion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 17, 2024 | ||||
| Seed | Jan 1, 2019 |
Key People
Founding team and executive leadership
Elion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Seed, Series A, Series B |
| AMR Action Fund | Series B |
| University of Illinois Foundation | Series B |
| Illinois Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Phase 2 study started for Turletricin (EL219) for invasive mould infections.
- Jun 17, 2024
$81M round led by Deerfield Management
Elion Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elion Therapeutics's valuation, stock price, and market status.